Petros Moustardas
Linkoeping, E, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Transcriptomic Analysis in a Model of Aniridia-Associated Keratopathy for Target Discovery and Evaluation of Duloxetine Therapy.
Journal: Investigative ophthalmology & visual science
Published: January 16, 2026
Central Corneal Epithelial Wounding Accelerates Aniridia-Associated Keratopathy in PAX6-Deficient Mice.
Journal: Investigative ophthalmology & visual science
Published: November 14, 2025
Long-term ocular symptoms following COVID-19 linked to immune dysregulation, dysautonomia and peripheral neuropathy.
Journal: Nature communications
Published: September 18, 2025
Targeting insulin receptor substrate-1 delays disease progression in a murine model of aniridia-associated keratopathy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 29, 2025
A human-like model of aniridia-associated keratopathy for mechanistic and therapeutic studies.
Journal: JCI insight
Published: June 18, 2024
Effects of miR-204-5p modulation on PAX6 regulation and corneal inflammation.
Journal: Scientific reports
Published: May 24, 2024
A double-crosslinked nanocellulose-reinforced dexamethasone-loaded collagen hydrogel for corneal application and sustained anti-inflammatory activity.
Journal: Acta biomaterialia
Published: June 03, 2023
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges.
Journal: Cells
Published: January 10, 2023
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
Journal: Frontiers in immunology
Published: May 21, 2022
Deregulation of the Kallikrein Protease Family in the Salivary Glands of the Sjögren's Syndrome ERdj5 Knockout Mouse Model.
Journal: Frontiers in immunology
Published: April 12, 2021
Last Updated: 09/26/2026